(NASDAQ: TWST) Twist Bioscience's forecast annual revenue growth rate of 14.84% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.76%.
Twist Bioscience's revenue in 2026 is $391,557,000.On average, 13 Wall Street analysts forecast TWST's revenue for 2026 to be $27,449,862,998, with the lowest TWST revenue forecast at $26,276,356,983, and the highest TWST revenue forecast at $28,326,007,248. On average, 13 Wall Street analysts forecast TWST's revenue for 2027 to be $31,643,583,551, with the lowest TWST revenue forecast at $29,768,058,526, and the highest TWST revenue forecast at $33,102,802,107.
In 2028, TWST is forecast to generate $36,487,821,284 in revenue, with the lowest revenue forecast at $34,068,461,445 and the highest revenue forecast at $38,497,618,942.